DelveInsight’s Drug Report

Malignant Pleural Mesothelioma Upcoming Therapies

Business Consultant, DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, DelveInsight's Oncology based Reports, Pharma Consultant, Snippets

Malignant pleural mesothelioma treatment market includes several immunotherapy agents, in the pipeline including Keytruda, Opdivo and...

Read More

Malignant pleural mesothelioma market: Elusive treatment approaches and Poor diagnosis

Articles, Business Consultant, DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, Pharma Consultant

Malignant pleural mesothelioma (MPM) is a malignancy of pleural layers within the lung cavity and inner sides of the ribs.  Year of...

Read More

Egg Allergy Market: Second most common food allergy but no approved therapy

Articles, Business Consultant, DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, Pharma Consultant

Hen’s egg allergy is the second most common type of allergy after cow’s milk. In infants and young children, Egg poses as one of the...

Read More

Chronic Hand Eczema Market

Articles, Business Consultant, DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, Pharma Consultant

Eczema is an umbrella term comprising skin disorders characterised by dry, discoloured, itchy and inflamed skin. Hand eczema (HE) are...

Read More

Atopic dermatitis market: Increasing prevalence and topical treatments

Articles, Business Consultant, DelveInsight's Drug Report, Pharma Consultant, pharma consultant

Atopic dermatitis, also known as atopic eczema, is a condition that results in itchy, scaly and red skin. It is an inflammatory skin...

Read More

Wave Life Sciences stocks implode; Amarin’s VASCEPA approval; GSK seeks approval

Business Consultant, DelveInsight's Drug Report, Pharma Consultant, The Business Cocktail

Wave Life Sciences has recently announced the discontinuation of its drug suvodirsen, for the treatment of a rare Duchenne Muscular...

Read More
Close